|
Jonathan Wilkin, MD Biography
Jonathan K. Wilkin, MD,
the founding director of the Division of Dermatology and Dental
Products at the US Food and Drug Administration, remains active in
regulatory matters after over 12 years of FDA service which included
membership on the FDA’s Dermatology Drugs Advisory Committee. Before
going to the FDA, he was Director of Dermatology at the Ohio State
University and Professor of Pharmacology and Medicine. He has over 130
publications in dermatology and clinical pharmacology.
Dr. Wilkin received his
BA and MS in zoology from Ohio State University in Columbus, followed by
his medical degree from the Ohio State University College of Medicine.
After a year of residency in obstetrics and gynecology at the University
of Louisville School of Medicine in Kentucky, he completed a residency
in dermatology at the University of Tennessee Health Science in Memphis,
where he was Chief Resident.
Dr. Wilkin has served
as chairman of the medical advisory board for the National Rosacea
Society since 1998 as well as having chaired their Expert Committees on
the Classification and Staging System for Rosacea. He also serves on the
American Academy of Dermatology’s (AAD) Ad Hoc Task Force on the
Academy’s Efforts with FDA and on their Environment and Drugs Committee.
Dr. Wilkin has been active in the American Society for Clinical
Pharmacology and Therapeutics, having chaired the Dermatologic and
Allergic Diseases Section and the Constitution and By-laws Committee for
several years, as well as serving in other capacities.
Dr. Wilkin is a fellow
of both the AAD and the American College of Physicians, a member of the
American Dermatological Association and board certified by both the
American Board of Dermatology and the American Board of Clinical
Pharmacology.
|